Home / Health / Dexcom G7 Boosts Blood Sugar Control in Type 2 Diabetes
Dexcom G7 Boosts Blood Sugar Control in Type 2 Diabetes
7 Jun
Summary
- Dexcom's G7 monitor enhanced blood sugar control in a study.
- The study focused on type 2 diabetes patients not using insulin.
- Results were presented at the American Diabetes Association meeting.
Medical device manufacturer Dexcom announced that its G7 continuous glucose monitor (CGM) has demonstrated improved blood sugar control in patients with type 2 diabetes who are not using insulin. This finding emerged from a study comparing the G7's performance against standard care.
The study results were officially presented this past Saturday at the American Diabetes Association conference. These findings indicate a positive impact of the G7 device on managing blood glucose levels for individuals with type 2 diabetes who do not require insulin therapy.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
